(Q43167835)

English

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients

scientific article published on 9 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 November 2017

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients (English)

1 reference

Europe PubMed Central

15 November 2017

0 references

6

1 reference

Europe PubMed Central

15 November 2017

object named as

Eleni Aklillu

3

0 references

Leif Bertilsson

5

object named as

Leif Bertilsson

1 reference

Europe PubMed Central

15 November 2017

1

object named as

Roza Ghotbi

1 reference

Europe PubMed Central

15 November 2017

author name string

Buster Mannheimer

2

1 reference

Europe PubMed Central

15 November 2017

Akira Suda

4

1 reference

Europe PubMed Central

15 November 2017

Urban Osby

7

1 reference

Europe PubMed Central

15 November 2017

publication date

9 February 2010

1 reference

Europe PubMed Central

15 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

15 November 2017

66

1 reference

Europe PubMed Central

15 November 2017

5

1 reference

Europe PubMed Central

15 November 2017

465-474

1 reference

Europe PubMed Central

15 November 2017

https://scigraph.springernature.com/pub.10.1007/s00228-009-0783-8

0 references

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine: an atypical antipsychotic for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome and olanzapine plasma levels in acute schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large intraindividual variability of olanzapine serum concentrations in adolescent patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiplex SNP genotyping in pooled DNA samples by a four-colour microarray system

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex, race, and smoking impact olanzapine exposure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition and biotransformation of the antipsychotic agent olanzapine in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20143052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-009-0783-8

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43167835&oldid=1982778154"